Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 04; 17(5):818-823.
View in:
PubMed
subject areas
Biological Products
Drug Approval
Humans
Inflammatory Bowel Diseases
authors with profiles
David T. Rubin